UB Paderborn / Katalog / Suche / in CDI

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex

Genome medicine, 2020-03, Vol.12 (1), p.27-8, Article 27

2020

Link zum Volltext

Verfügbarkeit prüfen

Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4498-4500

2009

Link zum Volltext

Verfügbarkeit prüfen

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1852-1854

2008

Link zum Volltext

Verfügbarkeit prüfen

Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis by Pyrosequencing Technology

Journal of Clinical Microbiology, 2006-06, Vol.44 (6), p.1925-1929

2006

Link zum Volltext

Verfügbarkeit prüfen

Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing

Journal of Clinical Microbiology, 2012-06, Vol.50 (6), p.2026-2033

2012

Link zum Volltext

Verfügbarkeit prüfen

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

Bulletin of the World Health Organization, 2012-09, Vol.90 (9), p.693-698

2012

Link zum Volltext

Verfügbarkeit prüfen

Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2003-09, Vol.47 (9), p.2971-2973

2003

Link zum Volltext

Verfügbarkeit prüfen

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Nature genetics, 2017-03, Vol.49 (3), p.395-402

2017

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk

International journal of mycobacteriology, 2013-12, Vol.2 (4), p.194-198

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2011-06, Vol.66 (6), p.1247-1254

2011

Link zum Volltext

Verfügbarkeit prüfen

Detection of Heteroresistant Mycobacterium tuberculosis by Pyrosequencing

Journal of Clinical Microbiology, 2013-12, Vol.51 (12), p.4210-4212

2013

Link zum Volltext

Verfügbarkeit prüfen

Rifampin-Isoniazid Oligonucleotide Typing: an Alternative Format for Rapid Detection of Multidrug-Resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology, 2010-12, Vol.48 (12), p.4386-4391

2010

Link zum Volltext

Verfügbarkeit prüfen

Resistance Levels and rpoB Gene Mutations among In Vitro-Selected Rifampin-Resistant Mycobacterium tuberculosis Mutants

Antimicrobial Agents and Chemotherapy, 2006-08, Vol.50 (8), p.2860-2862

2006

Link zum Volltext

Verfügbarkeit prüfen

Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions

International journal of mycobacteriology, 2012-09, Vol.1 (3), p.124-130

2012

Link zum Volltext

Verfügbarkeit prüfen

Detection of Drug-Resistant Mycobacterium tuberculosis

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1315, p.349

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2009-10, Vol.64 (4), p.786-793

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 (4), p.827-833

2011

Link zum Volltext

Verfügbarkeit prüfen

Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis

Antimicrobial agents and chemotherapy, 2011-09, Vol.55 (9), p.4492-4493

2011

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB

Journal of antimicrobial chemotherapy, 2016-02, Vol.71 (2), p.333-338

2016

Link zum Volltext

Verfügbarkeit prüfen

An outbreak investigation of Legionella non- pneumophila Legionnaires' disease in Sweden, April to August 2018: Gardening and use of commercial bagged soil associated with infections

Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-02, Vol.26 (7), p.9

2021

Link zum Volltext

Verfügbarkeit prüfen

Network Experiences from a Cross-Sector Biosafety Level-3 Laboratory Collaboration: A Swedish Forum for Biopreparedness Diagnostics

Health security, 2017-07, Vol.15 (4), p.384

2017

Link zum Volltext

Verfügbarkeit prüfen

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis/Remise en question d'un dogme: points de rupture des tests de sensibilite aux antimicrobiens de la Mycobacterium tuberculosis/Desafiar un dogma: valores limite en pruebas de sensibilidad antimicrobiana para Mycobacterium tuberculosis

Bulletin of the World Health Organization, 2012-09, Vol.90 (9), p.693

2012

Link zum Volltext

Verfügbarkeit prüfen

Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis

International journal of mycobacteriology, 2012-12, Vol.1 (4), p.177-179

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis

Tuberculosis (Edinburgh, Scotland), 2004, Vol.84 (5), p.311-316

2004

Link zum Volltext

Verfügbarkeit prüfen

Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats

Advances in experimental medicine and biology, 2017, Vol.972, p.123-129

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex

Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis by Pyrosequencing Technology

Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosis

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis

Detection of Heteroresistant Mycobacterium tuberculosis by Pyrosequencing

Rifampin-Isoniazid Oligonucleotide Typing: an Alternative Format for Rapid Detection of Multidrug-Resistant Mycobacterium tuberculosis

Resistance Levels and rpoB Gene Mutations among In Vitro-Selected Rifampin-Resistant Mycobacterium tuberculosis Mutants

Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions

Detection of Drug-Resistant Mycobacterium tuberculosis

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis

Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB

An outbreak investigation of Legionella non- pneumophila Legionnaires' disease in Sweden, April to August 2018: Gardening and use of commercial bagged soil associated with infections

Network Experiences from a Cross-Sector Biosafety Level-3 Laboratory Collaboration: A Swedish Forum for Biopreparedness Diagnostics

Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis

Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis

Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats

Suchergebnisse filtern